Innovative Medical Management Co.,Ltd. (SHE:002173)
China
· Delayed Price · Currency is CNY 23.19
+0.25 (1.09%)
Apr 29, 2026, 3:04 PM CST
SHE:002173 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 | 2021 - 2017 |
| Operating Revenue | 781.25 | 812.14 | 803.89 | 708.34 | 709.37 | Upgrade
|
| Other Revenue | - | 3.88 | 1.69 | 1.36 | 2.15 | Upgrade
|
| Revenue | 781.25 | 816.02 | 805.59 | 709.7 | 711.52 | Upgrade
|
| Revenue Growth (YoY) | -4.26% | 1.29% | 13.51% | -0.26% | -1.76% | Upgrade
|
| Cost of Revenue | 727.28 | 752.53 | 714 | 679.5 | 664.14 | Upgrade
|
| Gross Profit | 53.97 | 63.49 | 91.58 | 30.2 | 47.38 | Upgrade
|
| Selling, General & Admin | 111.05 | 114.89 | 118.02 | 118.82 | 122.12 | Upgrade
|
| Research & Development | 3.11 | - | - | - | - | Upgrade
|
| Other Operating Expenses | 9.53 | 11.11 | 9.68 | 3.7 | 6.52 | Upgrade
|
| Operating Expenses | 123.69 | 128.42 | 131.05 | 120.19 | 132.15 | Upgrade
|
| Operating Income | -69.72 | -64.93 | -39.47 | -89.99 | -84.78 | Upgrade
|
| Interest Expense | - | -4.09 | -3.65 | -3.35 | -6.06 | Upgrade
|
| Interest & Investment Income | 32.16 | 7.92 | 17.42 | 17.98 | 19.87 | Upgrade
|
| Other Non Operating Income (Expenses) | 5.04 | -1.14 | -0.43 | -6.94 | 2.41 | Upgrade
|
| EBT Excluding Unusual Items | -32.52 | -62.24 | -26.13 | -82.3 | -68.55 | Upgrade
|
| Gain (Loss) on Sale of Investments | 4.77 | 1.98 | -1.84 | - | 9.04 | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.02 | -1.42 | 1.06 | -1.16 | 0.06 | Upgrade
|
| Asset Writedown | -1.15 | -3.39 | -5.26 | -11.6 | -1.24 | Upgrade
|
| Legal Settlements | - | -34.89 | -3.17 | -15.59 | -40.59 | Upgrade
|
| Other Unusual Items | - | -0.67 | 0.38 | 35.36 | -1.79 | Upgrade
|
| Pretax Income | -28.88 | -100.63 | -34.96 | -75.28 | -103.08 | Upgrade
|
| Income Tax Expense | 7.37 | -6.65 | -0.68 | -1.69 | 0.27 | Upgrade
|
| Earnings From Continuing Operations | -36.26 | -93.99 | -34.29 | -73.6 | -103.36 | Upgrade
|
| Net Income to Company | -36.26 | -93.99 | -34.29 | -73.6 | -103.36 | Upgrade
|
| Minority Interest in Earnings | 1.4 | 0.03 | 0 | 0.17 | -0.11 | Upgrade
|
| Net Income | -34.85 | -93.95 | -34.29 | -73.42 | -103.46 | Upgrade
|
| Net Income to Common | -34.85 | -93.95 | -34.29 | -73.42 | -103.46 | Upgrade
|
| Shares Outstanding (Basic) | 436 | 447 | 429 | 445 | 450 | Upgrade
|
| Shares Outstanding (Diluted) | 436 | 447 | 429 | 445 | 450 | Upgrade
|
| Shares Change (YoY) | -2.62% | 4.39% | -3.77% | -0.99% | -1.31% | Upgrade
|
| EPS (Basic) | -0.08 | -0.21 | -0.08 | -0.16 | -0.23 | Upgrade
|
| EPS (Diluted) | -0.08 | -0.21 | -0.08 | -0.16 | -0.23 | Upgrade
|
| Free Cash Flow | -8.59 | -54.3 | -85.21 | -147.62 | -67.35 | Upgrade
|
| Free Cash Flow Per Share | -0.02 | -0.12 | -0.20 | -0.33 | -0.15 | Upgrade
|
| Gross Margin | 6.91% | 7.78% | 11.37% | 4.26% | 6.66% | Upgrade
|
| Operating Margin | -8.92% | -7.96% | -4.90% | -12.68% | -11.92% | Upgrade
|
| Profit Margin | -4.46% | -11.51% | -4.26% | -10.35% | -14.54% | Upgrade
|
| Free Cash Flow Margin | -1.10% | -6.65% | -10.58% | -20.80% | -9.47% | Upgrade
|
| EBITDA | 17.16 | 23 | 56.87 | 8.77 | 30.91 | Upgrade
|
| EBITDA Margin | 2.20% | 2.82% | 7.06% | 1.23% | 4.34% | Upgrade
|
| D&A For EBITDA | 86.88 | 87.93 | 96.34 | 98.76 | 115.69 | Upgrade
|
| EBIT | -69.72 | -64.93 | -39.47 | -89.99 | -84.78 | Upgrade
|
| EBIT Margin | -8.92% | -7.96% | -4.90% | -12.68% | -11.92% | Upgrade
|
| Revenue as Reported | - | 816.02 | 805.59 | 709.7 | 711.52 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.